🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
The overall purpose of the trial is to evaluate efficacy and safety of tiot...
Status
Completed
Location
205.456.01004 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01277523
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Start Date
2007-05
Trial ID
NCT00467740
Treatments Being Tested
Study to compare the lung and oropharyngeal deposition of Berodual® (fenote...
Status
Terminated
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT02176200
Treatments Being Tested
The primary objective of this study is to assess and compare the pharmacoki...
Status
Completed
Location
Teva Investigational Site 32170
Start Date
2013-01
Trial ID
NCT01785433
The deleterious consequences of lung hyperinflation seem not to be restrict...
Status
Completed
Location
Kingston General Hospital
Start Date
2017-01-01
Trial ID
NCT03425617
Treatments Being Tested
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
The decrease in physical activity due to increasing dyspnoea that over time...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2014-06
Trial ID
NCT02173769
Treatments Being Tested
The primary objective of this study is to assess the long-term efficacy and...
Status
Completed
Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Start Date
2009-01
Trial ID
NCT00796653
Treatments Being Tested
The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...
Status
Completed
Location
205.419.01058 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01172821